People · Operator
Named in public records as an officer, director or promoter · active 2009–2020 · Pharmaceuticals, Other Health Care, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Exalys Therapeutics, Inc. | — | Pharmaceuticals | Series A | $4.0M | $123.9M | 2020 |
| Siqro, Inc. | — | Other Health Care | Pre-Seed | $676K | $20.8M | 2009 |
| Puny Human, LLC | — | Other Technology | Pre-Seed | $100K | $4.2M | 2018 |
Michael Sanders at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Sanders on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Olav B. Bergheim | 1 | 13 |
| Dennis Podlesak | 1 | 6 |
| Eckard Weber, M.D. | 1 | 5 |
| Rick Orr | 1 | 5 |
| Lynne Rollins | 1 | 5 |
| NICOLE VITULLO | 1 | 4 |
| Brian Taylor Slingsby | 1 | 2 |
| Takeshi Taylor Takahashi | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.